Go Pro

MarketBeat Instant News Alerts

Cybin logo with Healthcare background

Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board

Cybin (NASDAQ:HELP), doing business as Helus Pharma, held its Annual General and Special Meeting of Shareholders, where shareholders were asked to consider resolutions related to the company’s auditor, board size, corporate name and director elections. Eric So, the company’s co-founder and executiv

NASDAQ:HELP
Read Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board
QuantaSing Group logo with Consumer Discretionary background

QuantaSing Group Q4 Earnings Call Highlights

Here Group reported fourth-quarter revenue of CNY127.7 million for fiscal 2026, an increase of 94.1% from a year earlier, as sales of existing and newly launched pop-toy intellectual property products rose. Full-year revenue reached CNY596.8 million, according to Founder, Chairman and Chief Executiv

NASDAQ:QSG
Read QuantaSing Group Q4 Earnings Call Highlights
AllianceBernstein Global High Income Fund logo with Finance background

AllianceBernstein Global High Income Fund, Inc. (NYSE:AWF) Plans $0.07 Monthly Dividend

AllianceBernstein Global High Income Fund, Inc. (NYSE:AWF) declared a monthly dividend on Monday, September 21st. Stockholders of record on Thursday, October 1st will be given a dividend of 0.0655 per share by the closed-end fund on Friday, October 16th. This represents a c) annualized dividend and a dividend yield of 7.9%. The ex-dividend date is Thursday, October 1st.

NYSE:AWF
Read AllianceBernstein Global High Income Fund, Inc. (NYSE:AWF) Plans $0.07 Monthly Dividend
Xenia Hotels & Resorts logo with Real Estate background

Xenia Hotels & Resorts, Inc. (NYSE:XHR) to Issue $0.14 Quarterly Dividend

Xenia Hotels & Resorts, Inc. (NYSE:XHR) declared a quarterly dividend on Monday, September 21st. Investors of record on Wednesday, September 30th will be paid a dividend of 0.14 per share by the real estate investment trust on Thursday, October 15th. This represents a c) annualized dividend and a dividend yield of 3.1%. The ex-dividend date is Wednesday, September 30th.

NYSE:XHR
Read Xenia Hotels & Resorts, Inc. (NYSE:XHR) to Issue $0.14 Quarterly Dividend
Travere Therapeutics logo with Healthcare background

Travere Therapeutics' (TVTX) "Outperform" Rating Reaffirmed at Wedbush

Wedbush reiterated an "outperform" rating and issued a $76.00 price objective on shares of Travere Therapeutics in a report on Tuesday.

NASDAQ:TVTX
Read Travere Therapeutics' (TVTX) "Outperform" Rating Reaffirmed at Wedbush
Nextpower logo with Industrials background

Nextpower (NASDAQ:NXT) Price Target Lowered to $116.00 at Robert W. Baird

Robert W. Baird decreased their target price on Nextpower from $156.00 to $116.00 and set an "outperform" rating for the company in a research note on Tuesday.

NASDAQ:NXT
Read Nextpower (NASDAQ:NXT) Price Target Lowered to $116.00 at Robert W. Baird

Trending News

All MarketBeat Instant News Alerts

Meta Platforms logo with Communication Services background

Jefferies Financial Group Raises Meta Platforms (NASDAQ:META) Price Target to $875.00

NASDAQ:META
Read Jefferies Financial Group Raises Meta Platforms (NASDAQ:META) Price Target to $875.00
Ionis Pharmaceuticals logo with Healthcare background

JPMorgan Chase & Co. Issues Pessimistic Forecast for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price

NASDAQ:IONS
Read JPMorgan Chase & Co. Issues Pessimistic Forecast for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price
Driven Brands logo with Consumer Discretionary background

Barclays Reaffirms "Equal Weight" Rating for Driven Brands (NASDAQ:DRVN)

NASDAQ:DRVN
Read Barclays Reaffirms "Equal Weight" Rating for Driven Brands (NASDAQ:DRVN)
Abivax logo with Healthcare background

Abivax (NASDAQ:ABVX) Given New $118.00 Price Target at Wedbush

NASDAQ:ABVX
Read Abivax (NASDAQ:ABVX) Given New $118.00 Price Target at Wedbush
Abivax logo with Healthcare background

Barclays Reaffirms Overweight Rating for Abivax (NASDAQ:ABVX)

NASDAQ:ABVX
Read Barclays Reaffirms Overweight Rating for Abivax (NASDAQ:ABVX)
Wabash National logo with Industrials background

Wabash National (NYSE:WNC) Given "Buy" Rating at DA Davidson

NYSE:WNC
Read Wabash National (NYSE:WNC) Given "Buy" Rating at DA Davidson
Constellation Brands logo with Consumer Staples background

Constellation Brands (NYSE:STZ) Price Target Lowered to $122.00 at Barclays

NYSE:STZ
Read Constellation Brands (NYSE:STZ) Price Target Lowered to $122.00 at Barclays
AutoZone logo with Consumer Discretionary background

AutoZone (NYSE:AZO) Announces Quarterly Earnings Results, Beats Expectations By $2.40 EPS

NYSE:AZO
Read AutoZone (NYSE:AZO) Announces Quarterly Earnings Results, Beats Expectations By $2.40 EPS
Heartflow logo with Healthcare background

Heartflow (NASDAQ:HTFL) Price Target Raised to $56.00 at Canaccord Genuity Group

NASDAQ:HTFL
Read Heartflow (NASDAQ:HTFL) Price Target Raised to $56.00 at Canaccord Genuity Group
Alkermes logo with Healthcare background

Alkermes (NASDAQ:ALKS) Price Target Raised to $61.00

NASDAQ:ALKS
Read Alkermes (NASDAQ:ALKS) Price Target Raised to $61.00
Valero Energy logo with Energy background

Valero Energy (NYSE:VLO) Given "Hold" Rating at Jefferies Financial Group

NYSE:VLO
Read Valero Energy (NYSE:VLO) Given "Hold" Rating at Jefferies Financial Group
GRAIL logo with Healthcare background

GRAIL (NASDAQ:GRAL) Stock Price Expected to Rise, Robert W. Baird Analyst Says

NASDAQ:GRAL
Read GRAIL (NASDAQ:GRAL) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Terrestrial Energy logo with Industrials background

Terrestrial Energy Inc. (NASDAQ:IMSR) Given Consensus Recommendation of "Hold" by Analysts

NASDAQ:IMSR
Read Terrestrial Energy Inc. (NASDAQ:IMSR) Given Consensus Recommendation of "Hold" by Analysts
Brinker International logo with Consumer Discretionary background

Brinker International (NYSE:EAT) Upgraded at Northcoast Research

NYSE:EAT
Read Brinker International (NYSE:EAT) Upgraded at Northcoast Research
Tiziana Life Sciences logo with Healthcare background

BTIG Research Reaffirms "Buy" Rating for Tiziana Life Sciences (NASDAQ:TLSA)

NASDAQ:TLSA
Read BTIG Research Reaffirms "Buy" Rating for Tiziana Life Sciences (NASDAQ:TLSA)
Atlanticus logo with Finance background

Atlanticus (NASDAQ:ATLC) Earns "Buy" Rating from BTIG Research

NASDAQ:ATLC
Read Atlanticus (NASDAQ:ATLC) Earns "Buy" Rating from BTIG Research
Upstart logo with Finance background

Upstart's (UPST) "Buy" Rating Reiterated at BTIG Research

NASDAQ:UPST
Read Upstart's (UPST) "Buy" Rating Reiterated at BTIG Research
Adaptive Biotechnologies logo with Healthcare background

Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research

NASDAQ:ADPT
Read Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research
PTC Therapeutics logo with Healthcare background

Cantor Fitzgerald Boosts PTC Therapeutics (NASDAQ:PTCT) Price Target to $137.00

NASDAQ:PTCT
Read Cantor Fitzgerald Boosts PTC Therapeutics (NASDAQ:PTCT) Price Target to $137.00
McGraw Hill logo with Consumer Discretionary background

BTIG Research Reiterates "Buy" Rating for McGraw Hill (NYSE:MH)

NYSE:MH
Read BTIG Research Reiterates "Buy" Rating for McGraw Hill (NYSE:MH)
Hyperfine logo with Healthcare background

BTIG Research Reiterates Buy Rating for Hyperfine (NASDAQ:HYPR)

NASDAQ:HYPR
Read BTIG Research Reiterates Buy Rating for Hyperfine (NASDAQ:HYPR)
Tyra Biosciences logo with Healthcare background

Tyra Biosciences (NASDAQ:TYRA) Price Target Lowered to $29.00 at HC Wainwright

NASDAQ:TYRA
Read Tyra Biosciences (NASDAQ:TYRA) Price Target Lowered to $29.00 at HC Wainwright
Eldorado Gold logo with Materials background

Eldorado Gold (NYSE:EGO) Stock Rating Upgraded by Bank of America

NYSE:EGO
Read Eldorado Gold (NYSE:EGO) Stock Rating Upgraded by Bank of America
Travere Therapeutics logo with Healthcare background

Travere Therapeutics' (TVTX) Buy Rating Reaffirmed at HC Wainwright

NASDAQ:TVTX
Read Travere Therapeutics' (TVTX) Buy Rating Reaffirmed at HC Wainwright

Featured Articles and Offers

Alert Categories

All Alerts